Ticker Details
Immunovant, Inc.
IPO Date:	June 7, 2019
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$5.22B
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.53 | 2.73%
Avg Daily Range (30 D):	$0.54 | 2.16%
Avg Daily Range (90 D):	$0.52 | 2.05%

Institutional Daily Volume
Avg Daily Volume:	.88M
Avg Daily Volume (30 D):	.99M
Avg Daily Volume (90 D):	1.2M

Trade Size
Avg Trade Size (Sh.):	76
Avg Trade Size (Sh.) (30 D):	59
Avg Trade Size (Sh.) (90 D):	63

Institutional Trades
Total Institutional Trades:	3,179
Avg Institutional Trade:	$2.32M
Avg Institutional Trade (30 D):	$3.06M
Avg Institutional Trade (90 D):	$2.93M
Avg Institutional Trade Volume:	.1M
Avg Institutional Trades (Per Day):	2

Market Closing Trades
Avg Closing Trade:	$3.73M
Avg Closing Trade (30 D):	$5.69M
Avg Closing Trade (90 D):	$6.21M
Avg Closing Volume:	165.89K

News

Apr 2, 2026 @ 9:00 AM Immunovant Announces Phase 3 Study Results for Bat... Source: Na

Feb 6, 2026 @ 12:00 PM Immunovant Provides Corporate Updates and Reports ... Source: Immunovant, Inc.

Dec 18, 2025 @ 7:35 AM Is Immunovant Stock a Buy After Roivant Sciences I... Source: Robert Izquierdo

Sep 17, 2025 @ 9:49 PM CENTURY ALUMINUM INVESTIGATION INITIATED BY FORMER... Source: Kahn Swick & Foti, Llc

Sep 3, 2025 @ 10:17 PM Why Immunovant Stock Blasted Higher Today Source: Eric Volkman

Financials
	TTM	Q2 2026	Q1 2026
Basic EPS	$-.61	$-.73	$-.71
Diluted EPS	$-.61	$-.73	$-.71
Revenue
Gross Profit
Net Income / Loss	$-110.64M	$-126.5M	$-120.61M
Operating Income / Loss
Cost of Revenue
Net Cash Flow	$-.38M	$-.88M	$.57M
PE Ratio